temozolomide has been researched along with Hemangiopericytoma in 3 studies
Hemangiopericytoma: A tumor composed of spindle cells with a rich vascular network, which apparently arises from pericytes, cells of smooth muscle origin that lie around small vessels. Benign and malignant hemangiopericytomas exist, and the rarity of these lesions has led to considerable confusion in distinguishing between benign and malignant variants. (From Dorland, 27th ed; DeVita Jr et al., Cancer: Principles & Practice of Oncology, 3d ed, p1364)
| Excerpt | Relevance | Reference |
|---|---|---|
| " Cases from June 2006 through October 2016 were identified for patients receiving bevacizumab and temozolomide for locally advanced, recurrent or metastatic solitary fibrous tumour or hemangiopericytoma, which is sometimes used to describe tumours arising from the meninges." | 3.91 | Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis. ( de Lemos, ML; Kang, I; Schaff, K, 2019) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (66.67) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Maeda, O | 1 |
| Ohka, F | 1 |
| Maesawa, S | 1 |
| Matsuoka, A | 1 |
| Shimokata, T | 1 |
| Mitsuma, A | 1 |
| Urakawa, H | 1 |
| Nakamura, S | 1 |
| Shimoyama, Y | 1 |
| Nakaguro, M | 1 |
| Wakabayashi, T | 1 |
| Ando, Y | 1 |
| de Lemos, ML | 1 |
| Kang, I | 1 |
| Schaff, K | 1 |
| Park, MS | 1 |
| Patel, SR | 1 |
| Ludwig, JA | 1 |
| Trent, JC | 1 |
| Conrad, CA | 1 |
| Lazar, AJ | 1 |
| Wang, WL | 1 |
| Boonsirikamchai, P | 1 |
| Choi, H | 1 |
| Wang, X | 1 |
| Benjamin, RS | 1 |
| Araujo, DM | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Solitary Fibrous Tumor: Phase II Study on Trabectedin Versus Adriamycin Plus Dacarbazine in Advanced Patients[NCT03023124] | Phase 2 | 50 participants (Anticipated) | Interventional | 2018-03-04 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 other studies available for temozolomide and Hemangiopericytoma
| Article | Year |
|---|---|
Solitary fibrous tumor/hemangiopericytoma treated with temozolomide plus bevacizumab: a report of four cases and literature review.
Topics: Antineoplastic Agents, Immunological; Bevacizumab; Drug-Related Side Effects and Adverse Reactions; | 2020 |
Efficacy of bevacizumab and temozolomide therapy in locally advanced, recurrent, and metastatic malignant solitary fibrous tumour: A population-based analysis.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Female; Hemangiopericytoma | 2019 |
Activity of temozolomide and bevacizumab in the treatment of locally advanced, recurrent, and metastatic hemangiopericytoma and malignant solitary fibrous tumor.
Topics: Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Beva | 2011 |